UBS AG has announced the filing of a pricing supplement for $810,000 in Trigger Autocallable Contingent Yield Notes linked to the common stock of Micron Technology, Inc. This offering, due November 1, 2029, showcases UBS's strategy to innovate within structured products, aiming to attract investors looking for contingent returns.
The filing was made on October 29, 2026, and is part of UBS's ongoing efforts to expand its product offerings in the competitive landscape of national commercial banks. The Notes feature a contingent coupon payment structure, which is dependent on the performance of the underlying asset, Micron Technology's stock.
Background
UBS AG is a prominent player in the financial services sector, classified under the Standard Industrial Classification (SIC) code 6021, which pertains to National Commercial Banks. The company operates primarily on the New York Stock Exchange (NYSE) under various tickers, including AMUB, BDCX, and others. As a non-accelerated filer, UBS continues to engage in strategic financial maneuvers to enhance its market position.
What the Filing Says
The recent filing indicates that the Notes are unsubordinated, unsecured debt obligations from UBS, linked to Micron Technology's common stock. The filing states, "UBS will pay a contingent coupon on the coupon payment date, plus any previously unpaid contingent coupons in respect of any previous observation dates..." This structure emphasizes the potential for both returns and risks associated with the investment.
Impact
This offering may attract a range of investors, including institutional and retail clients, who are interested in structured products that offer a combination of yield and risk exposure. The contingent nature of the Notes means that investors could face significant risks, including the potential loss of their principal investment if Micron's stock underperforms.
What's Next
The filing does not specify what happens next, but it indicates that UBS will continue to monitor the performance of the underlying asset and the market conditions surrounding the Notes.
Read Next
Delta Air Lines officer files to sell 44,950 shares
Aspen Neuroscience reports major stock transactions by director
Aspen Neuroscience Reports Major Stock Transactions by Investors
John P. Reed files to sell 179,020 shares of Arhaus, Inc.
Webull Corp Officer Files to Sell 107,692 Shares
Fermi Inc. files to sell 94,000 shares of common stock










